Analysis of lymphocyte subsets in patients with aplastic anemia before and during immunosuppressive therapy
✍ Scribed by U. Mentzel; H. Vogt; R. Rossol; R. G. Geissler; A. Maurer; A. Ganser; W. E. Trommer; D. Hoelzer
- Publisher
- Springer
- Year
- 1993
- Tongue
- English
- Weight
- 262 KB
- Volume
- 66
- Category
- Article
- ISSN
- 0939-5555
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
Immunoreactive serum erythropoietin (EPO) was measured in anemic and non-anemic patients with acquired non-severe aplastic anemia (AA; n = 22) and myelodysplastic syndromes (MDS; n = 31) receiving or not androgens to examine the effect of androgen therapy and anemia on EPO levels in these disorders.
By using Dexter-type long-term marrow cultures (D-LTMC), it has been shown previously that hematopoietic progenitor cells (HPC) from patients with aplastic anemia (AA) have a deficient proliferation in vitro. The studies reported to date, however, have focused exclusively on granulomonocytic progeni